miR-125b predicts childhood acute lymphoblastic leukaemia poor response to BFM chemotherapy treatment

BACKGROUND: Despite the favourable survival rates of childhood acute lymphoblastic leukaemia (ALL), a significant number of patients present resistance to antileukaemic agents and dismal prognosis. In this study, we analysed miR-125b expression in childhood ALL and evaluated its clinical utility for...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Br J Cancer
Päätekijät: Piatopoulou, Despina, Avgeris, Margaritis, Marmarinos, Antonios, Xagorari, Marieta, Baka, Margarita, Doganis, Dimitrios, Kossiva, Lydia, Scorilas, Andreas, Gourgiotis, Dimitrios
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Nature Publishing Group 2017
Aiheet:
Translational Therapeutics
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5589998/
https://ncbi.nlm.nih.gov/pubmed/28787435
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2017.256
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia